Psychoeducational Program for Cancer Patients.
1 other identifier
interventional
200
1 country
1
Brief Summary
The main objective of the study are:
- 1.To explore the effectiveness of psychoeducation program for cancer patients who refuse treatment because of irrational fears and anxieties.
- 2.To explore the effectiveness of psychoeducation program for cancer patients who have negative attitudes, and low motivation toward treatment which causes depression and affects the quality of life.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Nov 2023
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 15, 2023
CompletedFirst Submitted
Initial submission to the registry
November 23, 2023
CompletedFirst Posted
Study publicly available on registry
December 18, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
April 10, 2024
CompletedDecember 18, 2023
December 1, 2023
3 months
November 23, 2023
December 8, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
Treatment Refusal
Initially, we will enroll the patients for eligibility assessment and the eligible patients who are refusing medical (Chemotherapy, Radiation and Surgery) and psychological treatment (Counseling, psychotherapy) will be referred for psychological evaluations
3-5 weeks
Depression and Anxiety
Depression will be assessed by using Patient Health Questionnaire-9. A Score of 5, 10, 15, and 20 correspond to categorizations of mild, moderate, moderately severe, and severe depression respectively. Hospital Anxiety and Depression will be assessed by using Hospital Anxiety and Depression Scale. A score of 0-7 is considered normal, 8-10 as borderline and 11-21 as either anxious or depressed
after allocation (1 week)
Illness denial
Illness denial will be assessed by using Illness Denial Questionnaire. Higher score indicate high Illness denial whereas low score indicate low illness denial.
after allocation (1 week)
Motivation and Help-Seeking attitude
Motivation will be assessed by using Motivation and attitude towards changing health Scale. Higher score indicate higher motivation whereas low score indicate low motivation. Mental Help seeking attitude will be assessed by using Mental Help Seeking Attitude Scale. Higher score indicate high mental help seeking attitude whereas low score indicate low mental help seeking attitude.
after allocation (1 week)
Quality of Life Scale
Quality of Life will be measured by World Health Organization Quality of Life BREF. Higher score indicate high quality of life whereas low score indicate low quality of life
after allocation (1 week)
Secondary Outcomes (2)
Duration of illness
at the time of pre assessment (1 week)
stage of cancer
after allocation at pre-assessment (1 week)
Study Arms (2)
Treatment Group
EXPERIMENTALExperimental Group: Participants in the experimental group would receive 8-10 session of psychoeducational based Program. Waitlist control Group: Participants in the Control group would not receive psychoeducational Intervention.
Control Group
NO INTERVENTIONControl Group: Participants in the control group did not receive the said psychoeducational intervention.
Interventions
Psychoeducational Program would be used as an intervention stratégie for cancer patients to provide understanding and insight to the patients about the problems. Further, this program would address treatment refusal and illness denial, depressive symptoms, and treatment related irrational fears and anxiety. Moreover, this program will improve patients' motivation and attitude toward changing health, and quality of life.
Eligibility Criteria
You may qualify if:
- Participants who will be diagnosed with cancer at stage-I, II and III and who have refused medical and psychological treatment will be included in the treatment
- The second eligibility criterion of the participants would be at least mild score on PHD-9 to cross-check the mental health problems Participants they have diagnosed by the consultant after proper medical screening and evaluation will be included
- The patients would be taken from lower, middle and upper socioeconomic status.
- Their age range would be from 20-70 years.
You may not qualify if:
- Participants with medical and psychiatric comorbidities will be excluded
- The patients diagnosed with 4th stage would be excluded. Participants with serious medical condition will be excluded
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Qasir Abbas
Faisalābad, Punjab Province, 38000, Pakistan
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Qasir Abbas, PHD
Government College University, Faislabad.
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
November 23, 2023
First Posted
December 18, 2023
Study Start
November 15, 2023
Primary Completion
February 1, 2024
Study Completion
April 10, 2024
Last Updated
December 18, 2023
Record last verified: 2023-12
Data Sharing
- IPD Sharing
- Will not share